isopentenyladenosine has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Ciuffreda, P; Colombo, F; Dassano, A; De Cecco, L; Dragani, TA; Giardullo, P; Mancuso, M; Santaniello, E; Saran, A | 1 |
2 other study(ies) available for isopentenyladenosine and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
N(6)-isopentenyladenosine and analogs activate the NRF2-mediated antioxidant response.
Topics: Administration, Topical; Animals; Antioxidants; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Hydrogen Peroxide; Isopentenyladenosine; MCF-7 Cells; Mice; NF-E2-Related Factor 2; Otitis; Oxidation-Reduction; Reactive Oxygen Species; Signal Transduction; Tetradecanoylphorbol Acetate | 2014 |